source
- STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and moreEli Lilly is halving its originally planned investment in the production of weight loss syringes in Germany in response to a cost-cutting lawSTAT · 1mo ago↗ source
- Parabilis Medicines charts $413M IPO to back peptide pipelineParabilis Medicines, the peptide biotech led by former Johnson & Johnson R&D head Mathai Mammen, is seeking more than $400 million in its Nasdaq debut. If the drug developer follows through with it…Endpoints · 1mo ago↗ source
- Scientists uncover a new hiding spot for HIVAn Ebola update, Trump to strip job protections of NIH officials, and more health news from Morning RoundsSTAT · 1mo ago